Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion. 22 Sep Continue reading →
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning. 28 May Continue reading →
Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies. 27 May Continue reading →
Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury Continue reading →
Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress Continue reading →